About Celluminova

Celluminova specializes in developing new tools for stem cell research, including cancer stem cells. The patented biomarker GlioStem is intended for live stem cell detection and visualization.

The Team

Shirin Ilkhanizadeh

Shirin Ilkhanizadeh

Chief Executive Officer

Shirin is the CEO and co-founder of Celluminova. She holds a Master of Science in biomedicine and a PhD in neuroscience with focus on stem cell biology. She did her postdoctoral studies at University of California San Francisco (UCSF) where she studied cancer stem cells in malignant brain tumors and has experience from working in the pharmaceutical industry.

Anne-Christine (Anki) Nilsson

Anne-Christine (Anki) Nilsson

Chief Operating Officer

Anki holds a Master of Science in Biology and a PhD in clinical chemistry with focus on carbohydrate interactions. She did her postdoctoral studies at Karolinska Institutet, Huddinge, in a collaboration with Recopharma AB, a biotech company. Anki has experience from pre-clinical research and in vitro diagnostics in several Biotech- and MedTech-companies at management level.

Marcus Bäck

Marcus Bäck

Chief Technology Officer

Marcus holds a Master of Science in chemistry and a PhD in organic chemistry, with focus on medicinal chemistry. He has over 10 years of experience within the development of luminescent ligands for detection and characterization of disease associated cell types and protein aggregates.

Cassandra Stens

Cassandra Stens

Product and Market developer

Cassandra holds a Master of Science in Chemical Biology and Engineering from Linköping University.

Scroll